Switch to
View more

Gufic Biosciences Ltd

GUFICBIO
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,946 cr, stock is ranked 773
Moderate RiskStock is 2.94x as volatile as Nifty
200.802.10 (-1.03%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,946 cr, stock is ranked 773
Moderate RiskStock is 2.94x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
20.31
PB RatioPB Ratio
7.23
Dividend YieldDiv. Yield
Sector PESector PE
38.16
Sector PBSector PB
4.82
Sector Div YldSctr Div Yld
0.92%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.

Investor PresentationView older 

Aug 11, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

2019202020212022354.94384.63491.43782.2621.9422.7044.2395.84
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Investor Presentation 
Announced OnAug 11, 2022

Gufic Biosciences Limited has informed the Exchange about Investor Presentation | Download

Gufic Biosciences Limited has informed the Exchange about Investor Presentation | Download

Outcome of Board Meeting 
Announced OnAug 11, 2022

Gufic Biosciences Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider and approve inter-alia financial results for the quarter ended ended June 30, 2022 | Download

Gufic Biosciences Limited has informed the Exchange about Board Meeting held on 11-Aug-2022 to consider and approve inter-alia financial results for the quarter ended ended June 30, 2022 | Download

Cash Dividend 
Ex. DateSep 9, 2021

Final • Div/Share: ₹ 0.1

See all events